Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis
Background: Hyperinsulinemia associated with pituitary pars intermedia dysfunction (PPID) and/or equine metabolic syndrome (EMS) is well documented to put horses at high risk of laminitis. While dietary control of simple sugars and starch is the most effective therapy to control hyperinsulinemia, so...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tripoli University
2022-08-01
|
| Series: | Open Veterinary Journal |
| Subjects: | |
| Online Access: | https://www.openveterinaryjournal.com/OVJ-2022-03-053%20E.M.%20Kellon%20and%20K.M.%20Gustafson.pdf |